Calidi Biotherapeutics, Inc.Calidi Biotherapeutics, Inc.Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc.

No trades
No trades

Peers for comparison


Market capitalization
‪2.68 M‬ USDNano cap
−54.0728 USD
‪−25.58 M‬ USD
0.00 USD
‪3.64 M‬
Beta (1Y)
2.98
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
29
Change (1Y)
+1+3.57%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−882.03 K‬ USD

Company info


CEO
Eric E. Poma
Headquarters
San Diego
Founded
2014
ISIN
US3207035078
CUSIP
320703507
FIGI
BBG012QFCL84
Identifiers
ISIN US3207035078
CFI code
ESVUFR
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Calidi Biotherapeutics, Inc. is scheduled to release its next earnings report on Nov 17, 2026.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
CLDI stock is 4.57% volatile and has beta coefficient of 2.98.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like CLDI are typically less volatile than smaller companies

Track every detail on Calidi Biotherapeutics, Inc. stock chart and check out the list of the most volatile stocks — is Calidi Biotherapeutics, Inc. there?
To understand the CLDI stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +3.11%
– 1 week — +4.96%
– 1 month — −31.36%

CLDI all-time low was 0.6200 USD (Oct 22, 2026), and its highest price is 26,476.8000 USD (Aug 28, 2023). Find more dynamics in the Stock Heatmap and on the Calidi Biotherapeutics, Inc. stock chart.
Calidi Biotherapeutics, Inc. market capitalization is ‪2.68 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Calidi Biotherapeutics, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Calidi Biotherapeutics, Inc. stacks up against other companies
The safest way to buy Calidi Biotherapeutics, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade CLDI directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 9, 2026, the company has 29 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in Calidi Biotherapeutics, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Calidi Biotherapeutics, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our CLDI technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.
Calidi Biotherapeutics, Inc. stock ticker depends on the exchange where it’s listed. On the AMEX, its primary exchange, Calidi Biotherapeutics, Inc. stocks trade under the symbol CLDI.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
Yes, you can track Calidi Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
CLDI net income for the last quarter is ‪−4.16 M‬ USD, while the quarter before that showed ‪−4.42 M‬ USD of net income which accounts for 5.82% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Calidi Biotherapeutics, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Calidi Biotherapeutics, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
CLDI reached its all-time high of 26,476.8000 USD on Aug 28, 2023. Its all-time low was 0.6200 USD and was reached on Oct 22, 2026.

Explore the Calidi Biotherapeutics, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.